Richard Vosser
Stock Analyst at J.P. Morgan
(3.44)
# 2,317
Out of 5,065 analysts
1060
Total ratings
49.1%
Success rate
2.3%
Average return
Main Sectors:
Stocks Rated by Richard Vosser
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ETR: BAYN Bayer Aktiengesellschaft | Reiterated: Buy | €61.00 | €43.40 | +40.55% | 149 | Oct 16, 2026 | |
| SWX: ROP Roche Holding AG | Reiterated: Hold | CHF 325.00 | CHF 380.10 | -14.50% | 192 | Oct 12, 2026 | |
| ETR: SRT3 Sartorius Aktiengesellschaft | Reiterated: Buy | €295.00 | €260.40 | +13.29% | 77 | Oct 12, 2026 | |
| EPA: SAN Sanofi | Reiterated: Hold | €95.00 | €71.01 | +33.78% | 168 | Oct 7, 2026 | |
| LON: AZN AstraZeneca PLC | Reiterated: Buy | 16,000p | 12,400p | +29.03% | 41 | Sep 29, 2026 | |
| EPA: DIM Sartorius Stedim Biotech S.A. | Reiterated: Buy | €260.00 | €211.80 | +22.76% | 30 | Sep 28, 2026 | |
| SWX: NOVN Novartis AG | Reiterated: Buy | n/a | $124.20 | - | 121 | Sep 7, 2026 | |
| EPA: IPN Ipsen S.A. | Reiterated: Hold | n/a | $148.40 | - | 16 | Jun 29, 2026 | |
| ETR: MRK Merck KGaA | Reiterated: Buy | €150.00 | €144.35 | +3.91% | 145 | Jun 1, 2026 | |
| LON: GSK GSK plc | Reiterated: Sell | n/a | $1,855.00 | - | 7 | Dec 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $925 → $1,100 | $825.61 | +33.23% | 2 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 3.50 → CHF 3.00 | CHF 3.06 | -1.96% | 15 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $38.42 | - | 21 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $150.20 | - | 4 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4.5 → $4 | $3.66 | n/a | 8 | Sep 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €250.00 → €260.00 | €206.50 | n/a | 17 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | CHF 645.00 → CHF 650.00 | CHF 613.20 | n/a | 15 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €3.00 → €3.50 | €0.76 | n/a | 6 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $53 → $38 | $12.12 | n/a | 7 | Dec 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | €44.58 | €52.95 | n/a | 1 | Jan 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 3,000p | 1,665p | n/a | 7 | Sep 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $176 | $37.21 | n/a | 1 | Mar 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $57.14 | n/a | 3 | Dec 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $139 | $114.21 | n/a | 1 | Jul 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $205 → $200 | $29.79 | n/a | 2 | Mar 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | €185.00 | €26.46 | n/a | 1 | Jan 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $38.50 | n/a | 1 | Jan 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $39.57 | n/a | 1 | Apr 11, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $22 | $7.64 | n/a | 1 | Jan 4, 2017 |
Bayer Aktiengesellschaft
Oct 16, 2026
Reiterated: Buy
Price Target: €61.00
Current: €43.40
Upside: +40.55%
Roche Holding AG
Oct 12, 2026
Reiterated: Hold
Price Target: CHF 325.00
Current: CHF 380.10
Upside: -14.50%
Sartorius Aktiengesellschaft
Oct 12, 2026
Reiterated: Buy
Price Target: €295.00
Current: €260.40
Upside: +13.29%
Sanofi
Oct 7, 2026
Reiterated: Hold
Price Target: €95.00
Current: €71.01
Upside: +33.78%
AstraZeneca PLC
Sep 29, 2026
Reiterated: Buy
Price Target: 16,000p
Current: 12,400p
Upside: +29.03%
Sartorius Stedim Biotech S.A.
Sep 28, 2026
Reiterated: Buy
Price Target: €260.00
Current: €211.80
Upside: +22.76%
Novartis AG
Sep 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $124.20
Upside: -
Ipsen S.A.
Jun 29, 2026
Reiterated: Hold
Price Target: n/a
Current: $148.40
Upside: -
Merck KGaA
Jun 1, 2026
Reiterated: Buy
Price Target: €150.00
Current: €144.35
Upside: +3.91%
GSK plc
Dec 23, 2025
Reiterated: Sell
Price Target: n/a
Current: $1,855.00
Upside: -
Dec 8, 2025
Reiterated: Buy
Price Target: $925 → $1,100
Current: $825.61
Upside: +33.23%
Dec 8, 2025
Reiterated: Hold
Price Target: CHF 3.50 → CHF 3.00
Current: CHF 3.06
Upside: -1.96%
Nov 24, 2025
Reiterated: Buy
Price Target: n/a
Current: $38.42
Upside: -
Nov 20, 2025
Reiterated: Hold
Price Target: n/a
Current: $150.20
Upside: -
Sep 3, 2025
Reiterated: Hold
Price Target: $4.5 → $4
Current: $3.66
Upside: n/a
Jul 22, 2025
Reiterated: Buy
Price Target: €250.00 → €260.00
Current: €206.50
Upside: n/a
Dec 3, 2024
Reiterated: Buy
Price Target: CHF 645.00 → CHF 650.00
Current: CHF 613.20
Upside: n/a
Dec 3, 2024
Reiterated: Hold
Price Target: €3.00 → €3.50
Current: €0.76
Upside: n/a
Dec 5, 2023
Reiterated: Hold
Price Target: $53 → $38
Current: $12.12
Upside: n/a
Jan 3, 2023
Upgraded: Buy
Price Target: €44.58
Current: €52.95
Upside: n/a
Sep 27, 2021
Reiterated: Buy
Price Target: 3,000p
Current: 1,665p
Upside: n/a
Mar 18, 2021
Reiterated: Buy
Price Target: $176
Current: $37.21
Upside: n/a
Dec 21, 2020
Reiterated: Buy
Price Target: n/a
Current: $57.14
Upside: n/a
Jul 28, 2020
Reiterated: Buy
Price Target: $139
Current: $114.21
Upside: n/a
Mar 2, 2020
Reiterated: Hold
Price Target: $205 → $200
Current: $29.79
Upside: n/a
Jan 6, 2020
Downgraded: Hold
Price Target: €185.00
Current: €26.46
Upside: n/a
Jan 2, 2019
Downgraded: Hold
Price Target: n/a
Current: $38.50
Upside: n/a
Apr 11, 2017
Upgraded: Hold
Price Target: n/a
Current: $39.57
Upside: n/a
Jan 4, 2017
Upgraded: Buy
Price Target: $22
Current: $7.64
Upside: n/a